
New Microbes and New Infections, Journal Year: 2024, Volume and Issue: 63, P. 101557 - 101557
Published: Dec. 20, 2024
Language: Английский
New Microbes and New Infections, Journal Year: 2024, Volume and Issue: 63, P. 101557 - 101557
Published: Dec. 20, 2024
Language: Английский
Frontiers in Veterinary Science, Journal Year: 2025, Volume and Issue: 12
Published: Feb. 18, 2025
Poultry products are considered an important source of Salmonella infections. Transmission non-typhoidal enterica serovars to humans has been a great concern worldwide. Occurrence multi-drug resistance, adding the presence various virulence factors, which facilitate pathogenesis Salmonella, would cause tremendous risk for both human and animals' health. During 2023, out total number 1,274 samples from broilers in Iran, 114 isolates spp. (8.94%) were detected 97 confirmed as Enteritidis (SE). Eight genes including invA, sefA, sopE, spvC, hilA, agfA, sivH lpfA, among SE it was found that all harbored these at rate 100% except present 96.90% isolates. In phenotypic evaluation resistance against 16 antimicrobial agents, high rates observed nalidixic acid, ampicillin, amoxicillin-clavulanate ciprofloxacin. While tetracycline, streptomycin chloramphenicol be moderate, very low azithromycin, sulfamethoxazole-trimethoprim, amikacin, gentamicin, ceftriaxone cefotaxime. However, sensitive meropenem, ceftazidime aztreonam. The mean MAR index values 0.26 72.15% highly resistant. detection 14 isolates, five blaTEM, tetA, tetB, sul1 strA/B with prevalence 63.92, 36.08, 61.85, 10.30 14.43%, respectively. MDR SE, along overwhelming major factors raise public health concerns. These data highlight potential risks transmission pathogenic chicken meat sources, well need more effective surveillance use poultry industry. Reducing/optimizing antimicrobials, improving management procedures, using probiotics biosecurity or vaccines essential deal this issue.
Language: Английский
Citations
1Theoretical and Natural Science, Journal Year: 2025, Volume and Issue: 89(1), P. 78 - 85
Published: Jan. 15, 2025
Antibiotics are extensively employed worldwide for therapeutic purposes, often leading to overuse, which constitutes a contributing factor the emergence of antibiotic resistance (ABR). This phenomenon arises from diminished effectiveness antibiotics in treating bacterial infections due development. However, limitations experimental conditions and equipment making it challenging pinpoint precise sources resistance, consequently constraining breadth research on ABR. Genomic analysis antibiotic-resistant bacteria assists unveiling origins pathways dissemination. study employs Nanopore-based metagenomic sequencing, enabling direct sequencing microbial DNA within macrogenomic samples, thereby yielding comprehensive sequence data. Coupled with qPCR 16S rRNA gene datasets, this approach facilitates exploration distribution prevalence communities across different environments Focusing Scottish farmlands, isolated colonies were exposed (sulfamonomethoxine erythromycin) several weeks. By comparing them untreated control group microorganisms, identification genes (ABRGs), along their variations abundance, aims analyse impact these two species.
Language: Английский
Citations
0Journal of Taibah University for Science, Journal Year: 2025, Volume and Issue: 19(1)
Published: Feb. 10, 2025
Language: Английский
Citations
0Toxicology Reports, Journal Year: 2025, Volume and Issue: 14, P. 101969 - 101969
Published: Feb. 22, 2025
Language: Английский
Citations
0Journal of Consumer Protection and Food Safety, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 27, 2025
Language: Английский
Citations
0Russian Journal of General Chemistry, Journal Year: 2025, Volume and Issue: 95(3), P. 757 - 763
Published: March 1, 2025
Language: Английский
Citations
0Processes, Journal Year: 2025, Volume and Issue: 13(4), P. 1034 - 1034
Published: March 31, 2025
The extensive use of pharmaceuticals in human and veterinary medicine has led to their persistent environmental release, posing ecological public health risks. Major sources include manufacturing effluents, excretion, aquaculture, improper disposal, contributing bioaccumulation ecotoxicity. Mycoremediation is the fungal-mediated biodegradation pharmaceuticals, offers a promising sustainable approach mitigate pharmaceutical pollution. Studies have reported that certain fungal species, including Trametes versicolor Pleurotus ostreatus, can degrade up 90% contaminants, such as diclofenac, carbamazepine, ibuprofen, within days weeks, depending on conditions. Fungi produce range extracellular enzymes, laccases peroxidases, alongside intracellular enzymes like cytochrome P450 monooxygenases, which catalyze transformation complex compounds. These play an essential role modifying, detoxifying, mineralizing xenobiotics, thereby reducing persistence toxicity. effectiveness biotransformation influenced by factors substrate specificity, enzyme stability, Optimal degradation typically occurs at pH 4.5–6.0 temperatures 20–30 °C. Recent advancements engineering, immobilization techniques, bioreactor design improved catalytic efficiency process feasibility. However, scaling fungal-based remediation systems for large-scale applications remains challenge. Addressing these limitations with synthetic biology, metabolic other biotechnological innovations could further enhance enzymatic pharmaceuticals. This review highlights innovations, applications, challenges mycoremediation, emphasizing potential fungi transformative solution waste management.
Language: Английский
Citations
0New Microbes and New Infections, Journal Year: 2024, Volume and Issue: 63, P. 101557 - 101557
Published: Dec. 20, 2024
Language: Английский
Citations
0